Human induced pluripotent stem cells (hiPSCs) represent a powerful tool for the generation of specialized cells to be used in regenerative medicine as well as hepatocellular repopulation tool to treat liver metabolic diseases such as nonalcoholic steatohepatitis (NASH). Here we describe a strategy to obtain fully functional liver organoids from hiPSCs in a scalable manner. Our approach uses a two-step process, with a first step involving the scalable formation of homogeneous and uniform-sized human embryoid bodies (hEBs), followed by the application of a four-step liver differentiation protocol for the derivation of liver organoids that possess all the features of primary human hepatocytes. This chapter will also illustrate the characterization of the liver organoids by directed biomolecular techniques.
Keywords: Differentiation; Human embryoid bodies (hEBs); Human induced pluripotent stem cells (hiPSCs); Liver differentiation; Liver organoids; Regenerative medicine.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.